RP Investment Advisors’s Lux Health Tech Acquisition Corp. Class A Common Stock LUXA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,309,486
Closed -$12.9M 168
2022
Q1
$12.9M Buy
1,309,486
+152,435
+13% +$1.5M 1.81% 6
2021
Q4
$11.3M Buy
1,157,051
+322,162
+39% +$3.17M 1.41% 24
2021
Q3
$8.19M Buy
+834,889
New +$8.22M 1.1% 36
2021
Q1
Sell
-935,824
Closed -$10.1M 92
2020
Q4
$10.1M Buy
+935,824
New +$10M 2.72% 18

Other funds holding LUXA

RP Investment Advisors's LUXA Position: Q2 2022 in Review

RP Investment Advisors sold out of Lux Health Tech Acquisition Corp. Class A Common Stock (LUXA) in Q2 2022, closing a stake of 1,309,486 shares — an estimated $12.9M sold.

RP Investment Advisors first reported a position in LUXA in Q4 2020 and held it in 4 quarters. The position peaked at $12.9M in Q1 2022. 71 funds tracked by Wall St. Rank hold LUXA as of Q2 2022.

  • RP Investment Advisors reported no remaining Lux Health Tech Acquisition Corp. Class A Common Stock position as of Q2 2022 after selling out during the quarter.
  • RP Investment Advisors sold 1,309,486 Lux Health Tech Acquisition Corp. Class A Common Stock shares in Q2 2022, an estimated $12.9M.
  • RP Investment Advisors first reported a position in Lux Health Tech Acquisition Corp. Class A Common Stock in Q4 2020 and held it in 4 quarters.
  • RP Investment Advisors's Lux Health Tech Acquisition Corp. Class A Common Stock position peaked at $12.9M in Q1 2022.
  • 71 funds tracked by Wall St. Rank held Lux Health Tech Acquisition Corp. Class A Common Stock as of Q2 2022.

Based on RP Investment Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.